The number of people with susceptibility test result for rifampicin in Madagascar
Madagascar: The number of people with susceptibility test result for rifampicin was 4,142 in 2021. ◆ Volatile
Latest (2021)
4,142
Change on year
up 68,933.3%
World rank
35th
of 155 countries
All-time high
4,142
in 2021
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Madagascar, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Madagascar recorded 4,142 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
The figure is up 68,933.3% on the previous year.
Madagascar ranks 35th of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Madagascar, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 8 | — |
| 2020 | 6 | -25.0% |
| 2021 | 4,142 | +68933.3% |
Madagascar compared with similar countries
- Madagascar's 4,142 is above the median for low income countries, which is 1,934, 2.1× the median. (15 countries reporting)
- Madagascar's 4,142 is above the median for Sub-Saharan Africa, which is 2,015, 2.1× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.67 | 0 | 8 | 3 |
| 2020s | 2,074 | 6 | 4,142 | 2 |
Countries ranked near Madagascar
More health data for Madagascar
- Un projection of annual infant deaths, annual growth rate -1.87 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4912 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 920.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,569 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 63 (2025)
- Population ages 00-04, female, annual growth rate 1.32 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.071 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.3 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Madagascar?
- The number of people with susceptibility test result for rifampicin in Madagascar was 4,142 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Madagascar?
- The highest recorded value was 4,142 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Madagascar?
- The lowest recorded value was 0 in 2017.
- How does Madagascar rank for the number of people with susceptibility test result for rifampicin?
- Madagascar ranks 35th out of 155 countries with data for 2021.
- Where does this Madagascar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).